Yep picked that up as well Wilcox. But I will be betting that it...

First 8 Last

Share
Profile

Follow
Rob1000

541 Posts.

21

26/10/17

23:09

Post #: 28236201
Share

Originally posted by wilcox ↑

Colin Iles may, or may not be the right person to bring much needed technical and sales expertise to the company. I really hope so – but time will tell.
Despite no previous experience as a company director - I was hoping with his appointment – he might be bring some much needed change to the board’s reporting standards.

In the past, I have criticised the APG board – and I think with good reason.
But today I want to heap praise on the board – and for good reason.
For as long as I can remember (at least the last 12 years), APG directors Turbot, Cuthbertson & Harrison have had board meetings once a month, every month – and I can’t recall any of the directors ever missing even 1 of these crucial board meetings.
I have read a lot of other company reports – but by comparison, I believe the board meeting attendance record for APG directors over the last 12 years is truly outstanding.
To attend 12 board meetings a year, year in year out – says a lot about the selfless dedication of the APG directors.
APG shareholders will no doubt take pride in the gold star attendance record of their board.

But now APG has a new director – and I wonder if he is of the “right stuff” to serve on the APG board? Can he live up to the APG board’s exacting standards?

Mr Colin Iles was appointed to the APG board of directors on 13 March 2017. He was also appointed to the APG Audit committee in FY17.
In Financial Year ending 30/6/17 he was paid $25,000 in director’s fees for his 3.5 months on the board.
Mr Iles, as a director - should have attended 4 APG board meetings in FY 17.
Mr Iles did NOT attend any board of directors meetings in Financial Year ending 30/6/17.

I have no idea why director Iles is not attending board meetings – but I hope someone asks him why at he AGM.

Wilcox

Expand

Yep picked that up as well Wilcox. But I will be betting that it is an error. Because it does not say he was even eligible to attend. Also I do not think he was only payed $25,500.00 for the financial year.

They payed Company Sec $236,000 and the Auitor $ 96,885.00

APG Price at posting: 0.8¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

First 8 Last

Add APG (ASX) to my watchlist

Yep picked that up as well Wilcox. But I will be betting that it...

Top Stories

Resolute shares bounce back as second payment made to Mali government to secure workers' release

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher